Connext
Daegu
About Connext
Connext is developing biological therapeutics in the field of immuno-oncology and regenerative medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $14.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2026)
- Website: connext.co.kr
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/connext-24745 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.